Combination of chemotherapy and gemtuzumab ozogamicin in adult Philadelphia positive acute lymphoblastic leukemia patient harboring CD33 expression

International Journal of Hematology

Volumn 88, Issue 2, 2008, Pages 209-211

  Chevallier, Patrice ^a   Mahe, Beatrice ^a   Garand, Richard ^a   Talmant, Pascaline ^a   Harousseau, Jean Luc ^a   Delaunay, Jacques ^a  

^a NANTES UNIVERSITY HOSPITAL   (France)

Author keywords

ALL; CD33; Gemtuzumab; Mylotarg

Indexed keywords

ASPARAGINASE; BUSULFAN; CD33 ANTIGEN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; GEMTUZUMAB OZOGAMICIN; IDARUBICIN; IMATINIB; MITOXANTRONE; THYMOCYTE ANTIBODY; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ANTIGEN EXPRESSION; ARTICLE; CANCER CHEMOTHERAPY; CASE REPORT; CONDITIONING; DRUG MEGADOSE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HYPERBILIRUBINEMIA; MALE; NEUTROPENIA; PHILADELPHIA CHROMOSOME POSITIVE CELL; THROMBOCYTOPENIA;

ADULT; AMINOGLYCOSIDES; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; FATAL OUTCOME; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; PHILADELPHIA CHROMOSOME; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; REMISSION INDUCTION;

EID: 56649083639     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12185-008-0123-2     Document Type: Article

References (12)

1. PA Dinndorf RG Andrews D Benjamin D Ridgway L Wolff ID Berns 1986 Expression of normal myeloid associated antigens by acute leukaemia cells Blood 67 1048 53
2. RA Larson EL Sievers EA Stadtmauer B Löwenberg EH Estey H Dombret M Theobald D Voliotis JM Bennett M Richie LH Leopold MS Berger ML Sherman MR Loken JJ Van Dongen ID Bernstein FR Appelbaum 2005 Final report of the efficacy and safety of gemtuzumab ozogamicin (Mylotarg) in patients with CD33-positive acute myeloid leukemia in first recurrence Cancer 104 1442 52
3. CH Pui JE Rubnitz ML Hancock JR Downing SC Raimondi GK Rivera JT Sandlund RC Ribeiro DR Head MV Relling WE Evans FG Behm 1998 Reappraisal of the clinical and biologic significance of myeloid-associated antigen expression in childhood acute lymphoblastic leukaemia J Clin Oncol 16 3768 73
4. C Guglielmi I Cordone F Boecklin S Masi T Valentini ML Vegna A Ferrari AM Testi R Foa 1997 Immunophenotype of adult and childhood acute lymphoblastic leukemia: changes at first relapse and clinico-prognostic implications Leukemia 11 1501 7
5. A Balduzzi V Rossi L Corral S Bonanomi D Longoni A Rovelli V Conter A Biondi C Uderzo 2003 Molecular remission induced by gemtuzumab ozogamicin associated with donor lymphocyte infusions in t(4;11) acute lymphoblastic leukemia relapsed after transplantation Leukemia 17 2247 8
6. Cotter M, Rooney S, O'Marcaigh, Smith OP. Successful use of Gemtuzumab ozogamicin in a child with relapsed CD33-positive acute lymphoblastic leukaemia. Br J Haematol 2003;122:686-91.
7. Zwaan CM, Reihardt D, Jurgens H, Huismans DR, Hahlen K, Smith OP, Biondi a A, Van Wering ER, Feingold J, Kaspers GJ. Gemtuzumab ozogamicin in pediatric CD33 positive acute lymphoblastic leukemia: first clinical experiences and relation with cellular sensitivity to single agent calicheamicin. Leukemia 2003; 17:468-70.
8. P Chevallier V Roland B Mahe N Juge-Morineau V Dubruille T Guillaume S Vigouroux P Moreau N Milpied R Garand H Avet-Loiseau JL Harousseau 2005 Administration of mylotarg 4 days after beginning of a chemotherapy including intermediate-dose aracytin and mitoxantrone (MIDAM regimen) produces a high rate of complete hematologic remission in patients with CD33+ primary resistant or relapsed acute myeloid leukaemia Leuk Res 29 1003 7
9. AK Burnett WJ Kell AH Goldstone D Milligan A Hunter AG Prentice NH Russell B Gibson K Wheatley RK Hills 2006 The addition of Gemtuzumab Ozogamicin to induction chemotherapy for AML improves disease free survival without extra toxicity: preliminary analysis of 1115 patients in the MRC AML15 trial Blood 108 8a abstract 13
10. JP Laporte F Isnard L Garderet L Fouillard NC Gorin 2004 Remission of adult acute lymphocytic leukaemia with alemtuzumab Leukemia 18 1557 8
11. ES Morris A Vora 2007 Remission induction with single agent Rituximab in a child with multiply relapsed precursor-B ALL Br J Haematol 139 344 5
12. P Chevallier N Robillard S Wuilleme-Toumi F Mechinaud JL Harousseau H Avet-Loiseau 2004 Overexpression of Her2/neu is observed in one-third of adult acute lymphoblastic leukaemia patients and is associated with chemoresistance in these patients Haematologica 89 1399 401